Biotest has appointed Chindex as the exclusive distributor for its Tango Optimo automated blood bank system for the People's Republic of China. The Tango Optimo automates all routine testing procedures performed in blood banking, including blood grouping, antibody screening, and cross matching, and is the only blood bank analyzer that offers seven-day on-board storage of liquid and microplate reagents.
Upon receipt of regulatory approval from China's State Food and Drug Administration, Chindex will market the Tango Optimo to hospital laboratories along with the Johnson & Johnson Ortho Clinical Diagnostics line of clinical chemistry analyzers.
Under the terms of the agreement with Cutera, Chindex will market and distribute the upgradeable Xeo, Solera, and CoolGlide platforms in China and Hong Kong. The Cutera family of lasers, several of which have already been registered with the Chinese State Food and Drug Administration, provides an excellent complement to present Chindex product line.
Roberta Lipson, president and CEO of Chindex, said: "We are excited to be announcing these partnerships with industry-leading manufacturers that will widen the breadth of products that Chindex can now offer to China's healthcare communities. Importantly, both of these exclusive agreements leverage our existing leadership in their respective target markets in China."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index